-+ 0.00%
-+ 0.00%
-+ 0.00%

Tango Therapeutics Q2 EPS $(0.37) Misses $(0.32) Estimate

Benzinga·08/11/2026 11:27:53
Listen to the news
Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.32) by 15.62 percent. This is a 5.71 percent decrease over losses of $(0.35) per share from the same period last year.